Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
18.58 (1y: +59%)
Market Cap 20.66 B P/E(ttm) 38.20
Enterprise Value 23.78 B P/B 5.30
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyÂ’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 0.236
GIKLY's Cash to Debt is ranked lower than
89% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. GIKLY: 0.236 )
GIKLY' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.24
Equity to Asset -0.171
GIKLY's Equity to Asset is ranked lower than
699300% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.56 vs. GIKLY: -0.171 )
GIKLY' s 10-Year Equity to Asset Range
Min: -0.21   Max: 0.31
Current: -0.17
-0.21
0.31
Interest Coverage 2.6
GIKLY's Interest Coverage is ranked lower than
93% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 73.90 vs. GIKLY: 2.6 )
GIKLY' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: 2.6
Z-Score: 3.44
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyÂ’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) 25.20
GIKLY's Operating margin (%) is ranked higher than
84% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.00 vs. GIKLY: 25.20 )
GIKLY' s 10-Year Operating margin (%) Range
Min: 9.7   Max: 25.2
Current: 25.2
9.7
25.2
Net-margin (%) 9.8
GIKLY's Net-margin (%) is ranked lower than
54% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.20 vs. GIKLY: 9.8 )
GIKLY' s 10-Year Net-margin (%) Range
Min: 2.8   Max: 16.2
Current: 9.8
2.8
16.2
ROE (%) 13.7
GIKLY's ROE (%) is ranked higher than
63% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.30 vs. GIKLY: 13.7 )
GIKLY' s 10-Year ROE (%) Range
Min: 3   Max: 45.7
Current: 13.7
3
45.7
ROA (%) 4.6
GIKLY's ROA (%) is ranked lower than
68% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.30 vs. GIKLY: 4.6 )
GIKLY' s 10-Year ROA (%) Range
Min: 0.9   Max: 10.3
Current: 4.6
0.9
10.3
ROC (Joel Greenblatt) (%) 36.20
GIKLY's ROC (Joel Greenblatt) (%) is ranked higher than
57% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.40 vs. GIKLY: 36.20 )
GIKLY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 15.1   Max: 39.1
Current: 36.2
15.1
39.1
Revenue Growth (%) 27.3
GIKLY's Revenue Growth (%) is ranked higher than
98% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.60 vs. GIKLY: 27.3 )
GIKLY' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 27.3
Current: 27.3
0
27.3
EBITDA Growth (%) 28.3
GIKLY's EBITDA Growth (%) is ranked higher than
87% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.70 vs. GIKLY: 28.3 )
GIKLY' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 28.3
Current: 28.3
0
28.3
EPS Growth (%) 5.1
GIKLY's EPS Growth (%) is ranked lower than
85% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.30 vs. GIKLY: 5.1 )
GIKLY' s 10-Year EPS Growth (%) Range
Min: 0   Max: 31.1
Current: 5.1
0
31.1
» GIKLY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with GIKLY



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/E(ttm) 38.20
GIKLY's P/E(ttm) is ranked lower than
79% of the 107 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.90 vs. GIKLY: 38.20 )
GIKLY' s 10-Year P/E(ttm) Range
Min: 16.14   Max: 39.35
Current: 38.2
16.14
39.35
P/B 5.30
GIKLY's P/B is ranked lower than
86% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. GIKLY: 5.30 )
GIKLY' s 10-Year P/B Range
Min: 1.74   Max: 5.3
Current: 5.3
1.74
5.3
P/S 3.71
GIKLY's P/S is ranked lower than
67% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. GIKLY: 3.71 )
GIKLY' s 10-Year P/S Range
Min: 0.67   Max: 3.85
Current: 3.71
0.67
3.85
PFCF 29.00
GIKLY's PFCF is ranked lower than
59% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.70 vs. GIKLY: 29.00 )
GIKLY' s 10-Year PFCF Range
Min: 4.3   Max: 29.87
Current: 29
4.3
29.87
EV-to-EBIT 27.8
GIKLY's EV-to-EBIT is ranked lower than
73% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.73 vs. GIKLY: 27.8 )
GIKLY' s 10-Year EV-to-EBIT Range
Min: 8.6   Max: 17.3
Current: 27.8
8.6
17.3
PEG 1.4
GIKLY's PEG is ranked higher than
68% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. GIKLY: 1.4 )
GIKLY' s 10-Year PEG Range
Min: 0   Max: 2.2
Current: 1.4
0
2.2

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 12.1
GIKLY's Price/Net Current Asset Value is ranked higher than
60% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.00 vs. GIKLY: 12.1 )
GIKLY' s 10-Year Price/Net Current Asset Value Range
Min: 1.9   Max: 14.3
Current: 12.1
1.9
14.3
Price/Median PS Value 4.3
GIKLY's Price/Median PS Value is ranked lower than
97% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. GIKLY: 4.3 )
GIKLY' s 10-Year Price/Median PS Value Range
Min: 1.1   Max: 1.1
Current: 4.3
Earnings Yield (Greenblatt) 3.60
GIKLY's Earnings Yield (Greenblatt) is ranked lower than
72% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. GIKLY: 3.60 )
GIKLY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.6   Max: 11.6
Current: 3.6
3.6
11.6

Business Description

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Company Website
Industry: Medical Instruments & Supplies
Compare:
Traded in other countries:GRFS.USA, GRFP.Spain, GRF.Spain

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial